Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


26.11.2018

1 Ann Surg Oncol
2 Ann Thorac Surg
1 Arch Pathol Lab Med
3 Cancer Sci
2 Clin Lung Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
2 J Thorac Oncol
1 JAMA Oncol
4 Lancet Oncol
2 Lancet Respir Med
2 Lung Cancer
1 Lung Cancer (Auckl)
3 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. OKADA S, Shimada J, Kato D, Tsunezuka H, et al
    Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7061.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. TAMURA M, Matsumoto I, Tanaka Y, Saito D, et al
    Comparison between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2018 Nov 17. pii: S0003-4975(18)31664.
    PubMed     Text format     Abstract available

  3. YANG CJ, Shah S, Lin BK, Vandusen K, et al
    Right-sided vs Left-sided Pneumonectomy after Induction Therapy for Non-small-cell Lung Cancer.
    Ann Thorac Surg. 2018 Nov 15. pii: S0003-4975(18)31657.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  4. TROSCHEL FM, Gottumukkala RV, DiCorpo D, Mario J, et al
    Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study.
    Arch Pathol Lab Med. 2018 Nov 20. doi: 10.5858/arpa.2018-0249.
    PubMed     Text format     Abstract available


    Cancer Sci

  5. TAKAHASHI Y, Shien K, Tomida S, Oda S, et al
    Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
    Cancer Sci. 2018;109:3634-3642.
    PubMed     Text format     Abstract available

  6. KIM IG, Lee JH, Kim SY, Hwang HM, et al
    Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and gamma-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells.
    Cancer Sci. 2018;109:3519-3531.
    PubMed     Text format     Abstract available

  7. KIMURA S, Tanaka K, Harada T, Liu R, et al
    Sensitivity of epidermal growth factor receptor with single or double uncommon mutations to afatinib confirmed by a visual assay.
    Cancer Sci. 2018;109:3657-3661.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  8. GRANGEON M, Tomasini P, Chaleat S, Jeanson A, et al
    Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30263.
    PubMed     Text format     Abstract available

  9. MYALL NJ, Henry S, Wood D, Neal JW, et al
    Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 23. pii: S1525-7304(18)30264.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  10. DEMISSEI BG, Freedman G, Feigenberg SJ, Plastaras JP, et al
    Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer and lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33999.
    PubMed     Text format     Abstract available


    J Clin Oncol

  11. PENNELL NA, Neal JW, Chaft JE, Azzoli CG, et al
    SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2018 Nov 16:JCO1800131. doi: 10.1200/JCO.18.00131.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  12. KANG HR, Cho JY, Lee SH, Lee YJ, et al
    Role of low-dose computerized tomography in lung cancer screening among never-smokers.
    J Thorac Oncol. 2018 Nov 13. pii: S1556-0864(18)33417.
    PubMed     Text format     Abstract available

  13. SHIN DW, Cho J, Noh JM, Han H, et al
    Disparities in the diagnosis and treatment of lung cancer among people with disabilities.
    J Thorac Oncol. 2018 Nov 2. pii: S1556-0864(18)33407.
    PubMed     Text format     Abstract available


    JAMA Oncol

  14. SLOAN L, Romo CG, Hales RK
    Hemifacial Hyperhidrosis in a Patient With an Apical Non-Small Cell Lung Cancer.
    JAMA Oncol. 2018 Nov 15. pii: 2713851. doi: 10.1001/jamaoncol.2018.4597.
    PubMed     Text format    


    Lancet Oncol

  15. WU YL, Mok TS
    Dacomitinib in NSCLC: a positive trial with little clinical impact - Authors' reply.
    Lancet Oncol. 2018;19:e5.
    PubMed     Text format    

  16. PIRKER R
    EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation.
    Lancet Oncol. 2018;19:10-12.
    PubMed     Text format    

  17. NG TL, Camidge DR
    Lung cancer's real adjuvant EGFR targeted therapy questions.
    Lancet Oncol. 2018;19:15-17.
    PubMed     Text format    

  18. ADDEO A
    Dacomitinib in NSCLC: a positive trial with little clinical impact.
    Lancet Oncol. 2018;19:e4.
    PubMed     Text format    


    Lancet Respir Med

  19. BAAS P, Disselhorst M
    Immuno-oncology in malignant pleural mesothelioma.
    Lancet Respir Med. 2018;6:408-410.
    PubMed     Text format    

  20. ALTORKI NK, Wang X, Wigle D, Gu L, et al
    Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
    Lancet Respir Med. 2018 Nov 12. pii: S2213-2600(18)30411.
    PubMed     Text format     Abstract available


    Lung Cancer

  21. ZHAO B, Zhang W
    Reply to the comments on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials.
    Lung Cancer. 2018 Nov 12. pii: S0169-5002(18)30638.
    PubMed     Text format    

  22. SATO K, Akamatsu H, Murakami E, Sasaki S, et al
    Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71-74].
    Lung Cancer. 2018 Nov 17. pii: S0169-5002(18)30635.
    PubMed     Text format    


    Lung Cancer (Auckl)

  23. ARIDGIDES P, Nsouli T, Chaudhari R, Kincaid R, et al
    Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy for stage I non-small-cell lung cancer.
    Lung Cancer (Auckl). 2018;9:103-110.
    PubMed     Text format     Abstract available


    Oncol Rep

  24. XIA A, Li H, Li R, Lu L, et al
    Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Oncol Rep. 2018;40:2353-2362.
    PubMed     Text format     Abstract available

  25. ZHAO W, Hu JX, Hao RM, Zhang Q, et al
    Induction of microRNAlet7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1.
    Oncol Rep. 2018;40:1843-1854.
    PubMed     Text format     Abstract available

  26. LAM SK, U KP, Li YY, Xu S, et al
    Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models.
    Oncol Rep. 2018;40:1994-2004.
    PubMed     Text format     Abstract available


    PLoS One

  27. RAMELLA S, Fiore M, Greco C, Cordelli E, et al
    A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients.
    PLoS One. 2018;13:e0207455.
    PubMed     Text format     Abstract available

  28. OKOLI GN, Kostopoulou O, Delaney BC
    Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice.
    PLoS One. 2018;13:e0207686.
    PubMed     Text format     Abstract available

  29. PEREZ-MORALES J, Mejias-Morales D, Rivera-Rivera S, Gonzalez-Flores J, et al
    Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.
    PLoS One. 2018;13:e0207483.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: